143 related articles for article (PubMed ID: 37358639)
1. Relaxin-Loaded Inhaled Porous Microspheres Inhibit Idiopathic Pulmonary Fibrosis and Improve Pulmonary Function Post-Bleomycin Challenges.
Qiu S; Fu X; Shi Y; Zang H; Zhao Y; Qin Z; Lin G; Zhao X
Mol Pharm; 2023 Aug; 20(8):3947-3959. PubMed ID: 37358639
[TBL] [Abstract][Full Text] [Related]
2. Relaxin regulates myofibroblast contractility and protects against lung fibrosis.
Huang X; Gai Y; Yang N; Lu B; Samuel CS; Thannickal VJ; Zhou Y
Am J Pathol; 2011 Dec; 179(6):2751-65. PubMed ID: 21983071
[TBL] [Abstract][Full Text] [Related]
3. Inhaled B7 alleviates bleomycin-induced pulmonary fibrosis in mice.
Liu Y; Wang S; Gong X; Wang Y; Xu T
Bioorg Med Chem; 2021 Nov; 50():116482. PubMed ID: 34757292
[TBL] [Abstract][Full Text] [Related]
4. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
5. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
[TBL] [Abstract][Full Text] [Related]
6. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles.
Hu Y; Li M; Zhang M; Jin Y
Int J Pharm; 2018 Nov; 551(1-2):212-222. PubMed ID: 30227240
[TBL] [Abstract][Full Text] [Related]
7. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis.
Samuel CS; Zhao C; Bond CP; Hewitson TD; Amento EP; Summers RJ
Kidney Int; 2004 Jun; 65(6):2054-64. PubMed ID: 15149318
[TBL] [Abstract][Full Text] [Related]
8. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ
Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosis.
Kirsch JR; Williamson AK; Yeritsyan D; Blessing WA; Momenzadeh K; Leach TR; Williamson PM; Korunes-Miller JT; DeAngelis JP; Zurakowski D; Nazarian RM; Rodriguez EK; Nazarian A; Grinstaff MW
Sci Transl Med; 2022 Oct; 14(666):eabo3357. PubMed ID: 36223449
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
[TBL] [Abstract][Full Text] [Related]
11. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease.
Chakraborty A; Pinar AA; Lam M; Bourke JE; Royce SG; Selomulya C; Samuel CS
Biomaterials; 2021 Jun; 273():120796. PubMed ID: 33894403
[TBL] [Abstract][Full Text] [Related]
13. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease.
Mookerjee I; Solly NR; Royce SG; Tregear GW; Samuel CS; Tang ML
Endocrinology; 2006 Feb; 147(2):754-61. PubMed ID: 16254028
[TBL] [Abstract][Full Text] [Related]
14. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
[TBL] [Abstract][Full Text] [Related]
15. The relaxin gene knockout mouse: a model of progressive scleroderma.
Samuel CS; Zhao C; Yang Q; Wang H; Tian H; Tregear GW; Amento EP
J Invest Dermatol; 2005 Oct; 125(4):692-9. PubMed ID: 16185267
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
17. Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin).
Pini A; Boccalini G; Lucarini L; Catarinicchia S; Guasti D; Masini E; Bani D; Nistri S
J Pharmacol Exp Ther; 2016 Jun; 357(3):451-8. PubMed ID: 27048661
[TBL] [Abstract][Full Text] [Related]
18. The relaxin gene-knockout mouse: a model of progressive fibrosis.
Samuel CS; Zhao C; Bathgate RA; DU XJ; Summers RJ; Amento EP; Walker LL; McBurnie M; Zhao L; Tregear GW
Ann N Y Acad Sci; 2005 May; 1041():173-81. PubMed ID: 15956703
[TBL] [Abstract][Full Text] [Related]
19. Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.
Parikh A; Patel D; McTiernan CF; Xiang W; Haney J; Yang L; Lin B; Kaplan AD; Bett GC; Rasmusson RL; Shroff SG; Schwartzman D; Salama G
Circ Res; 2013 Jul; 113(3):313-21. PubMed ID: 23748429
[TBL] [Abstract][Full Text] [Related]
20. Role of transient receptor potential ankyrin 1 in idiopathic pulmonary fibrosis: modulation of M2 macrophage polarization.
Yang Y; Xiao Z; Yang W; Sun Y; Sui X; Lin X; Yang X; Bao Z; Cui Z; Ma Y; Li W; Wang S; Yang J; Wang Y; Luo Y
Cell Mol Life Sci; 2024 Apr; 81(1):187. PubMed ID: 38635081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
